0 items USD 0.00Search
Your search for "vancomycin market" gave back 1724080 results.
The global market for VRE and MRSA Antibiotic was valued at US$ 4384 million in the year 2024 and is projected to reach a revised size of US$ 5747...
颁补迟补濒辞驳:听
MRRPB5
April 2025
Price: USD 2,900.00
The global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs market size was valued at US$ 3235 million in 2023. With growing demand in...
颁补迟补濒辞驳:听
LPI
September 2024
Price: USD 3,660.00
The global C Difficile Infection Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the C Difficile...
颁补迟补濒辞驳:听
LPI
September 2024
Price: USD 3,660.00
Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE) are specific, antibiotic-resistant bacteria that spread...
颁补迟补濒辞驳:听
MRRPB5
February 2024
Price: USD 2,900.00
Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE) are specific, antibiotic-resistant bacteria that spread...
颁补迟补濒辞驳:听
MRRPB5
January 2023
Price: USD 2,900.00
MRSA is the result of decades of often unnecessary antibiotic use. For years, antibiotics have been prescribed for colds, flu and other viral...
颁补迟补濒辞驳:听
MRRPB5
October 2023
Price: USD 2,900.00
The global VRE and MRSA Antibiotic market size was valued at US$ 4511 million in 2024 and is forecast to a readjusted size of USD 5881 million by...
颁补迟补濒辞驳:听
GIR
July 2025
Price: USD 3,480.00
Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE) are specific, antibiotic-resistant bacteria that spread...
颁补迟补濒辞驳:听
GIR
September 2024
Price: USD 3,480.00
Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
颁补迟补濒辞驳:听
Global Markets Direct
November 2019
Price: USD 2,000.00
MRSA is the result of decades of often unnecessary antibiotic use. For years, antibiotics have been prescribed for colds, flu and other viral...
颁补迟补濒辞驳:听
MRRPB5
January 2024
Price: USD 2,900.00
MRSA is the result of decades of often unnecessary antibiotic use. For years, antibiotics have been prescribed for colds, flu and other viral...
颁补迟补濒辞驳:听
MRRPB5
September 2024
Price: USD 3,950.00
Refers to a class of antibiotics whose chemical nature is a polypeptide chain modified with sugar groups. Polypeptides that make up glycopeptide...
颁补迟补濒辞驳:听
MRRPB5
May 2024
Price: USD 2,900.00
Linezolid is a synthetic antibiotic, the first of the oxazolidinone class, used for the treatment of infections caused by multi-resistant bacteria...
颁补迟补濒辞驳:听
MRRPB5
June 2024
Price: USD 2,900.00
Febrile neutropenia, one of the most severe complications during cancer chemotherapy, is the development of fever with infection signals. The global...
颁补迟补濒辞驳:听
MRRPB5
February 2024
Price: USD 2,900.00
Refers to a class of antibiotics whose chemical nature is a polypeptide chain modified with sugar groups. Polypeptides that make up glycopeptide...
颁补迟补濒辞驳:听
MRRPB5
May 2023
Price: USD 2,900.00
听
